HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$5.26
Day range
$5.03 - $5.36
Year range
$3.76 - $19.35
Market cap
44.00M USD
Avg Volume
84.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.44M | 59.92% |
Net income | -10.94M | -72.32% |
Net profit margin | — | — |
Earnings per share | -1.34 | -78.67% |
EBITDA | -11.43M | -59.96% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.30M | -41.90% |
Total assets | 47.61M | -37.72% |
Total liabilities | 8.26M | 66.20% |
Total equity | 39.35M | — |
Shares outstanding | 8.61M | — |
Price to book | 1.15 | — |
Return on assets | -54.14% | — |
Return on capital | -64.15% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -10.94M | -72.32% |
Cash from operations | -10.54M | -49.47% |
Cash from investing | -7.00K | — |
Cash from financing | — | — |
Net change in cash | -10.55M | -186.42% |
Free cash flow | -7.10M | -28.03% |
About
Founded
2008
Headquarters
Website
Employees
14
